First-in-Class Therapy Targets “Undruggable” Protein in Hard-to-Treat Blood Cancers
The MYC protein is involved in about 70% of cancers, but scientists have been unable to develop drugs that effectively block it Researchers discovered a dependent relationship in which MYC…
